• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconThe Capsule

The Capsule

Page 5 of 9
Pharma collaboration competition COVID
NewslettersThe COVID pandemic pits competition against collaboration
By Sy MukherjeeFebruary 11, 2021
Would you get a COVID vaccine that’s less effective than other ones?
NewslettersWould you get a COVID vaccine that’s less effective than other ones?
By Sy MukherjeeFebruary 4, 2021
Biden health care executive orders
NewslettersPresident Biden’s health care sprint begins
By Sy MukherjeeJanuary 28, 2021
COVID vaccine shots
NewslettersA new president takes on one of the biggest vaccine challenges in history
By Sy MukherjeeJanuary 21, 2021
Pfizer Moderna COVID distribution
NewslettersPfizer or Moderna? A COVID vaccine distribution dilemma
By Sy MukherjeeJanuary 14, 2021
COVID vaccine distribution
NewslettersCOVID vaccine distribution gets off to a shaky start
By Sy MukherjeeJanuary 7, 2021
Pfizer COVID vaccine molecule to masses
NewslettersHow a molecule gets to the masses
By Sy MukherjeeDecember 17, 2020
Health care predictions 2021
NewslettersWhat happens next: 10 non-COVID health care predictions for 2021
By Sy MukherjeeDecember 10, 2020
What leaders can learn from a global pandemic
NewslettersWhat leaders can learn from a global pandemic
By Sy MukherjeeDecember 3, 2020
COVID19 Health Care System-Equity
NewslettersThe sad science of pandemic grief
By Sy MukherjeeNovember 19, 2020
Medical syringes are seen with Pfizer company logo displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
NewslettersThe scientific link between Pfizer’s and Moderna’s COVID vaccines
By Sy MukherjeeNovember 12, 2020
a blueprint for president-elect to fix america's health care mess
NewslettersThe election might be top of mind but 234,000 people are dead, with many in swing states
By Sy MukherjeeNovember 5, 2020
Two tales of innovation from CVS and Pfizer
NewslettersTwo tales of innovation from CVS and Pfizer
By Sy MukherjeeOctober 29, 2020
Gilead remdesivir price
NewslettersGilead just got the first FDA coronavirus treatment approval, but there are still problems
By Sy MukherjeeOctober 22, 2020
University of Colorado-Frshman COVID 19 Test
NewslettersHow chief health officers could help campuses navigate COVID
By Sy MukherjeeOctober 15, 2020
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...9
Most Popular
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
AI
A man used AI to call 3,000 Irish bartenders to track the cost of Guinness. Now pubs are lowering their prices to competeplaceholder alt text
By Fortune EditorsMarch 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.